Publications by authors named "Martin Helmuth"

Claim this Profile
M
Manipulation of DHPS activity affects dendritic morphology and expression of synaptic proteins in primary rat cortical neurons.
Paola Cavalli, Anna Raffauf, Sergio Passarella, Martin Helmuth, Daniela C Dieterich

Front Cell Neurosci· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methanol extract of Ficus platyphylla decreases cerebral ischemia induced injury in mice.
Axel Becker, Martin Helmuth, Doris Trzeczak, Ben A Chindo

J Ethnopharmacol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective activators of protein phosphatase 5 target the auto-inhibitory mechanism.
Veronika Haslbeck, Adrian Drazic, Julia M Eckl, Ferdinand Alte, Martin Helmuth

Biosci Rep· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outside or inside: role of the subcellular localization of DP4-like enzymes for substrate conversion and inhibitor effects.
Ute Bank, Anke Heimburg, Astrid Wohlfarth, Gudrun Koch, Karsten Nordhoff, Martin Helmuth

Biol Chem· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent insights into the role of dipeptidyl aminopeptidase IV (DPIV) and aminopeptidase N (APN) families in immune functions.
Siegfried Ansorge, Ute Bank, Anke Heimburg, Martin Helmuth, Gudrun Koch

Clin Chem Lab Med· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of alanyl-aminopeptidase on CD4+CD25+ regulatory T-cells enhances expression of FoxP3 and TGF-beta1 and ameliorates acute colitis in mice.
Ute Bank, Janine Tadje, Michael Täger, Carmen Wolke, Alicja Bukowska, Martin Helmuth

Int J Mol Med· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitors of dipeptidyl peptidase IV and aminopeptidase N target major pathogenetic steps in acne initiation.
Anja Thielitz, Dirk Reinhold, Robert Vetter, Ute Bank, Martin Helmuth

J Invest Dermatol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triggering endogenous immunosuppressive mechanisms by combined targeting of Dipeptidyl peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/ CD13)--a novel approach for the treatment of inflammatory bowel disease.
Ute Bank, Anke Heimburg, Martin Helmuth, Sofia Stefin, Uwe Lendeckel

Int Immunopharmacol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dipeptidylpeptidase IV (DPIV) and alanyl-aminopeptidases (AAPs) as a new target complex for treatment of autoimmune and inflammatory diseases-proof of concept in a mouse model of colitis.
Ute Bank, Janine Tadje, Martin Helmuth, Sofia Stefin, Michael Täger

Adv Exp Med Biol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Possible role of DP IV inhibitors in acne therapy.
Anja Thielitz, Dirk Reinhold, Robert Vetter, Uwe Lendeckel, Thilo Kähne, Martin Helmuth

Adv Exp Med Biol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis